Table 2.
Mean weekly number of radical episodes and attendances by month by diagnosis
|
Courses |
Attendances |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| February, 2020 | March, 2020 | April, 2020 | May, 2020 | June, 2020 | February, 2020 | March, 2020 | April, 2020 | May, 2020 | June, 2020 | |
| Anal cancer | ||||||||||
| Observed | 22 | 25 | 23 | 20 | 11 | 615 | 614 | 635 | 598 | 382 |
| Adjusted | 22 | 25 | 23 | 20 | 12 | 622 | 614 | 635 | 598 | 418 |
| SD | 6 | 5 | 7 | 4 | 1 | 45 | 25 | 27 | 49 | 63 |
| Percentage change | −4·4% | 21·5% | 9·7% | 2·6% | −48·9% | 11·2% | 8·7% | 16·7% | 12·5% | −27·2% |
| Bladder cancer | ||||||||||
| Observed | 20 | 28 | 45 | 55 | 26 | 370 | 521 | 730 | 992 | 674 |
| Adjusted | 20 | 28 | 45 | 55 | 28 | 373 | 521 | 730 | 992 | 737 |
| SD | 5 | 3 | 5 | 11 | 6 | 29 | 61 | 125 | 85 | 133 |
| Percentage change | −7·3% | −1·4% | 64·2% | 143·3% | 17·1% | −27·9% | 3·7% | 37·4% | 87·0% | 48·8% |
| Brain cancer | ||||||||||
| Observed | 58 | 51 | 43 | 42 | 41 | 1325 | 1145 | 948 | 845 | 817 |
| Adjusted | 58 | 51 | 43 | 42 | 45 | 1338 | 1145 | 948 | 845 | 893 |
| SD | 9 | 7 | 7 | 4 | 7 | 76 | 67 | 55 | 80 | 66 |
| Percentage change | −10·6% | −24·7% | −19·9% | −28·4% | −22·6% | 10·6% | −20·0% | −26·7% | −25·1% | −33·0% |
| Breast cancer | ||||||||||
| Observed | 634 | 597 | 570 | 618 | 493 | 9617 | 9289 | 6036 | 5400 | 4828 |
| Adjusted | 640 | 597 | 570 | 618 | 539 | 9715 | 9289 | 6036 | 5400 | 5279 |
| SD | 41 | 43 | 92 | 90 | 35 | 362 | 556 | 347 | 640 | 326 |
| Percentage change | 1·3% | −4·5% | −4·5% | 6·6% | −12·5% | 2·8% | −5·7% | −34·8% | −39·9% | −45·4% |
| Cervical cancer | ||||||||||
| Observed | 21 | 21 | 22 | 17 | 13 | 520 | 471 | 563 | 464 | 360 |
| Adjusted | 21 | 21 | 22 | 17 | 14 | 525 | 471 | 563 | 464 | 394 |
| SD | 4 | 7 | 5 | 5 | 4 | 48 | 30 | 15 | 49 | 18 |
| Percentage change | −10·9% | 6·3% | 0·7% | −37·7% | −32·7% | −9·9% | −16·6% | 12·2% | −19·3% | −37·6% |
| Head and neck cancer | ||||||||||
| Observed | 122 | 120 | 132 | 116 | 80 | 3249 | 3337 | 3415 | 3319 | 2467 |
| Adjusted | 124 | 120 | 132 | 116 | 87 | 3282 | 3337 | 3415 | 3319 | 2698 |
| SD | 14 | 16 | 23 | 23 | 3 | 98 | 62 | 147 | 205 | 249 |
| Percentage change | −0·2% | 4·2% | 9·7% | 4·0% | −25·6% | −6·6% | −2·9% | 5·1% | 3·4% | −18·8% |
| Lung cancer | ||||||||||
| Observed | 135 | 140 | 139 | 147 | 102 | 1955 | 2089 | 1893 | 1884 | 1350 |
| Adjusted | 136 | 140 | 139 | 147 | 111 | 1974 | 2089 | 1893 | 1884 | 1476 |
| SD | 7 | 13 | 13 | 22 | 19 | 77 | 72 | 80 | 155 | 158 |
| Percentage change | 6·8% | 8·5% | −1·9% | 10·8% | −11·5% | 8·2% | 9·0% | −5·8% | −0·1% | −21·5% |
| Lymphoma | ||||||||||
| Observed | 55 | 52 | 40 | 49 | 45 | 760 | 706 | 523 | 497 | 556 |
| Adjusted | 56 | 52 | 40 | 49 | 49 | 768 | 706 | 523 | 497 | 608 |
| SD | 5 | 9 | 7 | 9 | 4 | 31 | 56 | 48 | 84 | 5 |
| Percentage change | 5·9% | −5·5% | −19·2% | 23·1% | −1·7% | 12·2% | −10·8% | −25·1% | −14·2% | −7·9% |
| Oesophageal cancer | ||||||||||
| Observed | 24 | 30 | 46 | 43 | 25 | 519 | 621 | 735 | 1110 | 658 |
| Adjusted | 25 | 30 | 46 | 43 | 28 | 524 | 621 | 735 | 1110 | 720 |
| SD | 2 | 8 | 17 | 11 | 2 | 19 | 18 | 142 | 81 | 109 |
| Percentage change | −14·8% | 1·9% | 41·2% | 71·3% | −3·2% | −9·1% | −7·3% | 9·5% | 79·8% | 18·8% |
| Other cancer diagnosis | ||||||||||
| Observed | 148 | 124 | 107 | 113 | 115 | 2642 | 2284 | 1858 | 1837 | 1886 |
| Adjusted | 149 | 124 | 107 | 113 | 125 | 2668 | 2284 | 1858 | 1837 | 2062 |
| SD | 14 | 8 | 19 | 12 | 10 | 93 | 221 | 96 | 92 | 117 |
| Percentage change | 2·4% | −8·0% | −17·8% | 2·3% | −3·6% | 9·5% | −11·0% | −19·2% | −15·9% | −10·2% |
| Prostate cancer | ||||||||||
| Observed | 372 | 285 | 80 | 144 | 285 | 8471 | 7958 | 3706 | 2174 | 4595 |
| Adjusted | 375 | 285 | 80 | 144 | 311 | 8557 | 7958 | 3706 | 2174 | 5025 |
| SD | 30 | 115 | 11 | 54 | 44 | 249 | 976 | 852 | 224 | 1125 |
| Percentage change | −10·9% | −25·3% | −77·0% | −58·0% | −13·7% | −12·4% | −14·3% | −55·7% | −72·5% | −39·7% |
| Rectal cancer | ||||||||||
| Observed | 72 | 76 | 94 | 80 | 37 | 1435 | 1445 | 1252 | 907 | 602 |
| Adjusted | 73 | 76 | 94 | 80 | 41 | 1449 | 1445 | 1252 | 907 | 658 |
| SD | 7 | 9 | 24 | 14 | 9 | 30 | 68 | 82 | 171 | 41 |
| Percentage change | −5·2% | −5·7% | 36·3% | 22·3% | −43·7% | 9·5% | 0·2% | −8·6% | −29·3% | −55·8% |
| Non-melanoma skin cancer | ||||||||||
| Observed | 94 | 65 | 22 | 34 | 59 | 949 | 747 | 389 | 352 | 618 |
| Adjusted | 94 | 65 | 22 | 34 | 64 | 959 | 747 | 389 | 352 | 676 |
| SD | 18 | 24 | 3 | 8 | 6 | 84 | 133 | 56 | 59 | 104 |
| Percentage change | −12·7% | −29·2% | −72·4% | −57·8% | −28·4% | −8·5% | −24·7% | −52·5% | −56·7% | −28·8% |
Observed weekly mean, weekly mean adjusted for missing data with SD, and percentage change compared with the corresponding month in 2019 based on adjusted data are presented. Where diagnoses including small numbers of courses are considered, the adjustment for missing data must be interpreted with caution.